Lithium and recurrence in a long-term follow-up of bipolar affective disorder

Psychological Medicine

Volumn 27, Issue 2, 1997, Pages 281-289

  Coryell, W ^a,b   Winokur, G ^a   Solomon, D ^a   Shea, T ^a   Leon, A ^a   Keller, M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b 2887 JPP ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; MULTICENTER STUDY; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RELAPSE; TIME;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; TREATMENT OUTCOME;

EID: 0030894062     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291796004461     Document Type: Article

References (41)

1. Baldessarini, R. J. (1995). Risks and implications of interrupting maintenance psychotropic drug therapy. Psychotherapy and Psychosomatics 63, 137-141.
2. Coppen, A., Noguera, R., Bailey, J., Burns, B. H., Swani, M. S., Have, E. H., Gardner, R. & Maggs, R. (1971). Prophylactic lithium in affective disorders. Lancet ii, 275-279.
3. Coppen, A., Abou-Saleh, M., Milln, P., Bailey, J. & Wood, K. (1983). Decreasing lithium dosage reduces morbidity and side effects during prophylaxis. Journal of Affective Disorders 5, 353-362.
4. Coryell, W., Endicott, J., Maser, J. D., Mueller, T., Lavori, P. & Keller, M. (1995). The likelihood of recurrence in bipolar affective disorder: the importance of episode recency. Journal of Affective Disorders 33, 201-206.
5. Dickson, W. E. & Kendell, R. E. (1986). Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions? Psychological Medicine 16, 521-530.
6. Endicott, J. & Spitzer, R. L. (1978). A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry 35, 837-844.
7. Endicott, J., Spitzer, R. J., Fleiss, J. L. & Cohen, J. (1976). The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33, 766-771.
8. Faedda, G. L., Tondo, L., Baldessarini, R. J., Suppes, T. & Tohen, M. (1993). Outcome after rapid versus gradual discontinuation of lithium treatment in bipolar disorders. Archives of General Psychiatry 50, 448-455.
9. Fieve, R. R., Kumberaci, T. & Dunner, D. L. (1976). Lithium prophylaxis of depression in bipolar I and bipolar II and unipolar patients. American Journal of Psychiatry 133, 925-929.
10. Frank, E., Prien, R. F., Jarrett, R. B., Keller, M. B., Kupfer, D. J., Lavori, P. W., Rush, A. J. & Weissman, M. M. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Archives of General Psychiatry 48, 851-855.
11. Fyro, B. & Petterson, U. (1977). A double-blind study of the prophylactic effect of lithium in manic depressive disease. Acta Psychiatrica Scandinavica 262, 17-22.
12. Gelenberg, A. J., Kane, J. M., Keller, M. B., Lavori, P., Rosenbaum, J. F., Cole, K. & Lavelle, J. (1989). Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. New England Journal of Medicine 321, 1489-1493.
13. Goodwin, F. K. & Jamison, K. R. (1990). Manic-Depressive Illness. Oxford University Press: New York.
14. Guscott, R. & Taylor, L. (1994). Lithium prophylaxis in recurrent affective illness: efficacy, effectiveness and efficiency. British Journal of Psychiatry 164, 741-746.
15. Harrow, M., Goldberg, J. F., Grossman, L. S. & Meltzer, H. Y. (1990). Outcome in manic disorders. Archives of General Psychiatry 47, 665-671.
16. Kalbfleisch, J. D. & Prentice, R. L. (1980). The Statistical Analysis Of Failure Time Data, pp. 12-15. Wiley and Sons: New York.
17. Kaplan, E. L. & Meier, P. (1958). Non-parametric estimation from incomplete observations. Journal of the American Statistical Association 53, 457-481.
18. Keller, M. B., Lavori, P. W., Klerman, G. L., Andreasen, N. C., Endicott, J., Coryell, W., Fawcett, J. & Hirschfeld, R. M. A. (1986). Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Archives of General Psychiatry 43, 458-466.
19. Keller, M. B., Lavori, P. W., Friedman, B., Neilsen, E., Endicott, J., McDonald-Scott, P. & Andreasen, N. C. (1987). The longitudinal interval follow-up evaluation. Archives of General Psychiatry 44, 540-548.
20. Lavori, P. W., Dawson, R. & Mueller, T. B. (1994a). Causal estimation of time-varying treatment effects in observational studies: application to depressive disorder. Statistics in Medicine 13, 1089-1100.
21. Lavori, P. W., Keller, M. B., Mueller, T. I., Scheftner, W., Fawcett J. & Coryell, W. (1994b). Recurrence after recovery in unipolar MDD: an observational follow-up study of clinical predictors and somatic treatment as a mediating factor. International Journal of Methods in Psychiatric Research 4, 211-229.
22. Maj, M., Strace, F., Nolfe, G. & Kemali, D. (1986). Minimal plasma lithium levels required for affective prophylaxis in DSM-III bipolar disorder: a prospective study. Pharmacopsychiatry 19, 20-423.
23. Maj, M., Pirozzi, R. & Kemali, D. (1991). Long-term outcome of lithium prophylaxis in bipolar patients. Archives of General Psychiatry 48, 772.
24. Mander, A. J. & Loudon, J. B. (1988). Rapid recurrence of mania following abrupt discontinuation of lithium. Lancet ii, 15-17.
25. Markar, H. R. & Mander, A. J. (1989). Efficacy of lithium prophylaxis in clinical practice. British Journal of Psychiatry 155, 496-500.
26. Mendlewicz, J. (1984). Lithium discontinuation in bipolar illness: a double-blind prospective controlled study. In Current Trends in Lithium and Rubidium Therapy (ed. G. V. Corsini), pp. 135-141. MTP Press: Lancaster.
27. Molnar, G. & Fava, G. A. (1989). Long-term follow-up of patients on managed lithium discontinuation. Psychopharmacology Bulletin 25, 250-252.
28. Molnar, G., Pristach, C., Feeney, M. G. & Fava, G. A. (1988). A pilot study of managed lithium discontinuation. Psychopharmacology Bulletin 24, 217-219.
29. Peselow, E. D., Fieve, R. R., Difiglia, C. & Sanfilipo, M. P. (1994). Lithium prophylaxis of bipolar illness. British Journal of Psychiatry 164, 208-214.
30. Poole, A. J., James, H. D. & Hugh, W. C. (1978). Treatment experiences in the Lithium Clinic at St. Thomas Hospital. Journal of the Royal Society of Medicine 71, 890-894.
31. Prien, R. F., Klett, J. & Caffey, E. M. (1974a). Lithium prophylaxis in recurrent affective illness. American Journal of Psychiatry 131, 198-203.
32. Prien, R. F., Caffey, E. M. & Klett, J. (1974b). Factors associated with treatment success on lithium carbonate prophylaxis. Archives of General Psychiatry 31, 189-192.
33. Prien, R. F., Kupfer, D. J., Mansky, P. A., Small, J. G., Tuason, V. B., Voss, C. B. & Johnson, W. E. (1984). Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Archives of General Psychiatry 41, 1096-1104.
34. Rybakowski, J., Chlopocka-Wozinak, M., Kapelski, Z. & Strzyzeski, W. (1980). The relative prophylactic efficacy of lithium against manic and depressive recurrences in bipolar patients. International Pharmacopsychiatry 15, 86-90.
35. Sashidharan, S. P. & McGuire, R. J. (1983). Recurrence of affective illness after withdrawal of long-term lithium treatment. Acta Psychiatrica Scandinavica 68, 126-133.
36. Schou, M. (1993). Is there a lithium withdrawal syndrome? An examination of the evidence. British Journal of Psychiatry 163, 514-518.
37. Spitzer, R. L., Endicott, J. & Robins, E. (1978). Research Diagnostic Criteria (3rd edn). Biometrics Research, New York State Department of Mental Hygiene: New York.
38. Stallone, F., Shelley, E., Mendlewicz, J. & Fieve, R. R. (1973). The use of lithium in affective disorders. III. A double blind study of prophylaxis in bipolar illness. American Journal of Psychiatry 130, 1006-1010.
39. Suppes, T., Baldessarini, R. J., Faedda, G. L. & Tohen, M. (1991). Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Archives of General Psychiatry 48, 1082-1088.
40. Waters, B., Lapierre, Y., Gagnon, A., Caheudhry, R., Tremblay, A., Sarantidis, D. & Gray, R. (1982). Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder. Biological Psychiatry 16, 1323-1329.
41. Winokur, G., Coryell, W., Akiskal, H., Endicott, J., Keller, M. & Mueller, T. (1994). Manic depressive (bipolar) disorder: the course in light of a prospective 10-year follow-up of 131 patients. Acta Psychiatrica Scandinavica 89, 102-110.